AION Labs is a venture studio built to connect pharma R&D with the next wave of AI, technology, and scientific innovation.

Founded by AstraZeneca, Pfizer, Merck, and Teva, together with AWS and leading venture capital partners, AION Labs' mission is to harness AI and emerging technologies to accelerate the creation, validation, and scaling of solutions that transform drug discovery and development. We work closely with founders and entrepreneurs through deep, hands-on collaboration with global pharmaceutical leaders. Our co-development venture studio model combines pharma-defined unmet needs, world-class scientific expertise, and structured company-building support - significantly reducing early risk and shortening time to value.
Companies built at AION Labs gain early access to pharma insights, R&D champions, real-world validation opportunities, mentorship, and funding, enabling faster progress with strong industry alignment. By fostering cross-industry partnerships and rapid learning cycles, we turn innovation into execution.

In just three years, AION Labs has launched nine companies, enabled multiple pharma pilots and collaborations across drug R&D, and achieved strong market validation through follow-on funding, up-rounds, and a strategic M&A. Together with our partners, we are shaping the future of pharma - delivering more efficient, scalable, and impactful innovation and brings real value to patients worldwide.

  • Industry-Driven
    Ideation

    We start with real, high-impact challenges - defined and validated with AION Labs’ pharma partners to ensure strong relevance and focus on true unmet needs.

  • Unparalleled Pharma
    Access & Validation

    Direct access to pharma R&D teams and subject-matter experts enables early validation across biology, technology, and feasibility, including POCs built around real-world pharma constraints.

  • Venture Building
    & Scale

    We combine hands-on venture building with comprehensive support - funding, talent sourcing, data and cloud infrastructure, and full operational backing - from ideation through growth and follow-on capital.